Copyright
©The Author(s) 2018.
World J Gastroenterol. Oct 7, 2018; 24(37): 4254-4262
Published online Oct 7, 2018. doi: 10.3748/wjg.v24.i37.4254
Published online Oct 7, 2018. doi: 10.3748/wjg.v24.i37.4254
Table 1 Tumor formation rate and tumor load in each group
| Group | n | Tumor formation rate (%) | Tumor load (cm) | P value (vs model group) |
| 5-ASA | 20 | 65.0 (13/20) | 0.43 ± 0.14 | 0.0269 |
| VSL#3 | 20 | 65.0 (13/20) | 0.25 ± 0.07 | 0.0009 |
| 5-ASA + VSL#3 | 19 | 63.2 (12/19) | 0.46 ± 0.11 | 0.0261 |
| Model | 19 | 100.0 (19/19) | 0.97 ± 0.19 | - |
| Control | 10 | 0 | 0 | - |
- Citation: Wang CSE, Li WB, Wang HY, Ma YM, Zhao XH, Yang H, Qian JM, Li JN. VSL#3 can prevent ulcerative colitis-associated carcinogenesis in mice. World J Gastroenterol 2018; 24(37): 4254-4262
- URL: https://www.wjgnet.com/1007-9327/full/v24/i37/4254.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i37.4254